Apart from mitoxantrone-resistant colon cancer cells, BCRP has also been observed to be overexpressed in a myriad of mitoxantrone-resistant cancer cell lines, including myeloma, fibrosarcoma, glioblastoma, and gastric carcinoma[20,27]. Here, ABCG2 is linked to malignant colon neoplasm.